On Jan 28, 2026, CNMD reported earnings of 1.43 USD per share (EPS) for Q4 25, beating the estimate of 1.34 USD, resulting in a 5.94% surprise. Revenue reached 373.20 million, compared to an expected 374.13 million, with a -0.25% difference. The market reacted with a -3.57% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 7 analysts forecast an EPS of 0.83 USD, with revenue projected to reach 316.65 million USD, implying an decrease of -41.96% EPS, and decrease of -15.15% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Pro-Dex Inc New
Report Date
Jan 29, 2026 For Q2 26
Estimate
$0.60
Actual
$0.66
Surprise
+9.67%
Lifevantage Corporation Common Stock (Delaware)
Report Date
Feb 04, 2026 For Q2 26
Estimate
$0.15
Actual
$0.15
Surprise
-1.96%
McKesson Corporation
Report Date
Feb 04, 2026 For Q3 26
Estimate
$9.30
Actual
$9.34
Surprise
+0.33%
Cardinal Health, Inc.
Report Date
Feb 05, 2026 For Q2 26
Estimate
$2.37
Actual
$2.63
Surprise
+10.57%
Align Technology Inc
Report Date
Feb 04, 2026 For Q4 25
Estimate
$3.03
Actual
$3.29
Surprise
+8.55%
FAQ
What were CONMED Corporation's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, CONMED Corporation reported EPS of $1.43, beating estimates by 5.94%, and revenue of $373.20M, -0.25% below expectations.
How did the market react to CONMED Corporation's Q4 2025 earnings?
The stock price moved down -3.57%, changed from $38.69 before the earnings release to $37.31 the day after.
When is CONMED Corporation expected to report next?
The next earning report is scheduled for Apr 28, 2026.
What are the forecasts for CONMED Corporation's next earnings report?
Based on 7
analysts, CONMED Corporation is expected to report EPS of $0.83 and revenue of $316.65M for Q1 2026.